- Home
- BNTC vs ZVRA Comparison
BNTC vs ZVRA Comparison
Compare BNTC & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- ZVRA
- Stock Information
- Founded
- BNTC 1995
- ZVRA 2006
- Country
- BNTC United States
- ZVRA United States
- Employees
- BNTC N/A
- ZVRA N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- BNTC Health Care
- ZVRA Health Care
- Exchange
- BNTC Nasdaq
- ZVRA Nasdaq
- Market Cap
- BNTC 366.6M
- ZVRA 400.8M
- IPO Year
- BNTC N/A
- ZVRA 2015
- Fundamental
- Price
- BNTC $14.42
- ZVRA $9.07
- Analyst Decision
- BNTC Strong Buy
- ZVRA Strong Buy
- Analyst Count
- BNTC 6
- ZVRA 8
- Target Price
- BNTC $23.83
- ZVRA $22.29
- AVG Volume (30 Days)
- BNTC 72.3K
- ZVRA 538.5K
- Earning Date
- BNTC 05-14-2025
- ZVRA 08-12-2025
- Dividend Yield
- BNTC N/A
- ZVRA N/A
- EPS Growth
- BNTC N/A
- ZVRA N/A
- EPS
- BNTC N/A
- ZVRA N/A
- Revenue
- BNTC N/A
- ZVRA $40,588,000.00
- Revenue This Year
- BNTC N/A
- ZVRA $292.31
- Revenue Next Year
- BNTC N/A
- ZVRA $78.65
- P/E Ratio
- BNTC N/A
- ZVRA N/A
- Revenue Growth
- BNTC N/A
- ZVRA 46.47
- 52 Week Low
- BNTC $5.74
- ZVRA $4.20
- 52 Week High
- BNTC $17.15
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- BNTC 44.90
- ZVRA 58.37
- Support Level
- BNTC $14.42
- ZVRA $8.71
- Resistance Level
- BNTC $17.10
- ZVRA $9.37
- Average True Range (ATR)
- BNTC 1.20
- ZVRA 0.33
- MACD
- BNTC -0.18
- ZVRA -0.05
- Stochastic Oscillator
- BNTC 3.66
- ZVRA 50.93
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.